Comments Regarding Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use Share page: Docket Number: FDA–2021–N–0862 Download Document Issues: OTC Medicines Rx-to-OTC Switch Related Posts Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025 Press Releases and Statements Veteran Scientist & Regulator Joins CHPA’s Senior Management Team May 12, 2025 Press Releases and Statements CHPA Submits Official Comments on Section 232 National Security Investigation of Pharmaceuticals May 8, 2025